Global Non-Invasive Cancer Detection Supply, Demand and Key Producers, 2024-2030
Page: 103
Published Date: 01 Oct 2024
Category: Service & Software
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
Non-invasive cancer testing is a technology that detects cancer by analyzing biomarkers in body fluids such as blood, urine, and saliva without surgery or tissue biopsy. Common non-invasive testing methods include liquid biopsy, genetic testing, and imaging technology, which can detect cancer-related DNA, RNA, proteins, or circulating tumor cells (CTCs) to detect cancer early or monitor disease progression. Non-invasive testing is more comfortable for patients and has lower risks, and is particularly suitable for cancer screening, treatment effect evaluation, and recurrence monitoring.
The global Non-Invasive Cancer Detection market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).
This report studies the global Non-Invasive Cancer Detection demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Non-Invasive Cancer Detection, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Non-Invasive Cancer Detection that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Non-Invasive Cancer Detection total market, 2019-2030, (USD Million)
Global Non-Invasive Cancer Detection total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Non-Invasive Cancer Detection total market, key domestic companies, and share, (USD Million)
Global Non-Invasive Cancer Detection revenue by player, revenue and market share 2019-2024, (USD Million)
Global Non-Invasive Cancer Detection total market by Type, CAGR, 2019-2030, (USD Million)
Global Non-Invasive Cancer Detection total market by Application, CAGR, 2019-2030, (USD Million)
This report profiles major players in the global Non-Invasive Cancer Detection market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Trublood, Datar Cancer Genetics, Nucleix, miR Scientific, Owlstone Medical, bioAffinity Technologies, Nonacus, Amadix, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Non-Invasive Cancer Detection market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Non-Invasive Cancer Detection Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Non-Invasive Cancer Detection Market, Segmentation by Type
Imaging Test
Nuclear Medicine Test
Others
Global Non-Invasive Cancer Detection Market, Segmentation by Application:
Prostate Cancer
Bladder Cancer
Pancreatic Cancer
Breast Cancer
Gastric Cancer
Others
Companies Profiled:
Trublood
Datar Cancer Genetics
Nucleix
miR Scientific
Owlstone Medical
bioAffinity Technologies
Nonacus
Amadix
Key Questions Answered
1. How big is the global Non-Invasive Cancer Detection market?
2. What is the demand of the global Non-Invasive Cancer Detection market?
3. What is the year over year growth of the global Non-Invasive Cancer Detection market?
4. What is the total value of the global Non-Invasive Cancer Detection market?
5. Who are the Major Players in the global Non-Invasive Cancer Detection market?
6. What are the growth factors driving the market demand?
Table of Contents
1 Supply Summary
1.1 Non-Invasive Cancer Detection Introduction
1.2 World Non-Invasive Cancer Detection Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Non-Invasive Cancer Detection Total Market by Region (by Headquarter Location)
1.3.1 World Non-Invasive Cancer Detection Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Based Company Non-Invasive Cancer Detection Revenue (2019-2030)
1.3.3 China Based Company Non-Invasive Cancer Detection Revenue (2019-2030)
1.3.4 Europe Based Company Non-Invasive Cancer Detection Revenue (2019-2030)
1.3.5 Japan Based Company Non-Invasive Cancer Detection Revenue (2019-2030)
1.3.6 South Korea Based Company Non-Invasive Cancer Detection Revenue (2019-2030)
1.3.7 ASEAN Based Company Non-Invasive Cancer Detection Revenue (2019-2030)
1.3.8 India Based Company Non-Invasive Cancer Detection Revenue (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Non-Invasive Cancer Detection Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2.1 World Non-Invasive Cancer Detection Consumption Value (2019-2030)
2.2 World Non-Invasive Cancer Detection Consumption Value by Region
2.2.1 World Non-Invasive Cancer Detection Consumption Value by Region (2019-2024)
2.2.2 World Non-Invasive Cancer Detection Consumption Value Forecast by Region (2025-2030)
2.3 United States Non-Invasive Cancer Detection Consumption Value (2019-2030)
2.4 China Non-Invasive Cancer Detection Consumption Value (2019-2030)
2.5 Europe Non-Invasive Cancer Detection Consumption Value (2019-2030)
2.6 Japan Non-Invasive Cancer Detection Consumption Value (2019-2030)
2.7 South Korea Non-Invasive Cancer Detection Consumption Value (2019-2030)
2.8 ASEAN Non-Invasive Cancer Detection Consumption Value (2019-2030)
2.9 India Non-Invasive Cancer Detection Consumption Value (2019-2030)
3.1 World Non-Invasive Cancer Detection Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Non-Invasive Cancer Detection Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Non-Invasive Cancer Detection in 2023
3.2.3 Global Concentration Ratios (CR8) for Non-Invasive Cancer Detection in 2023
3.3 Non-Invasive Cancer Detection Company Evaluation Quadrant
3.4 Non-Invasive Cancer Detection Market: Overall Company Footprint Analysis
3.4.1 Non-Invasive Cancer Detection Market: Region Footprint
3.4.2 Non-Invasive Cancer Detection Market: Company Product Type Footprint
3.4.3 Non-Invasive Cancer Detection Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4.1 United States VS China: Non-Invasive Cancer Detection Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Non-Invasive Cancer Detection Revenue Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Non-Invasive Cancer Detection Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Non-Invasive Cancer Detection Consumption Value Comparison
4.2.1 United States VS China: Non-Invasive Cancer Detection Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Non-Invasive Cancer Detection Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Non-Invasive Cancer Detection Companies and Market Share, 2019-2024
4.3.1 United States Based Non-Invasive Cancer Detection Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Non-Invasive Cancer Detection Revenue, (2019-2024)
4.4 China Based Companies Non-Invasive Cancer Detection Revenue and Market Share, 2019-2024
4.4.1 China Based Non-Invasive Cancer Detection Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Non-Invasive Cancer Detection Revenue, (2019-2024)
4.5 Rest of World Based Non-Invasive Cancer Detection Companies and Market Share, 2019-2024
4.5.1 Rest of World Based Non-Invasive Cancer Detection Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Non-Invasive Cancer Detection Revenue (2019-2024)
5.1 World Non-Invasive Cancer Detection Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Imaging Test
5.2.2 Nuclear Medicine Test
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Non-Invasive Cancer Detection Market Size by Type (2019-2024)
5.3.2 World Non-Invasive Cancer Detection Market Size by Type (2025-2030)
5.3.3 World Non-Invasive Cancer Detection Market Size Market Share by Type (2025-2030)
6.1 World Non-Invasive Cancer Detection Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Prostate Cancer
6.2.2 Bladder Cancer
6.2.3 Pancreatic Cancer
6.2.4 Breast Cancer
6.2.5 Gastric Cancer
6.2.6 Others
6.3 Market Segment by Application
6.3.1 World Non-Invasive Cancer Detection Market Size by Application (2019-2024)
6.3.2 World Non-Invasive Cancer Detection Market Size by Application (2025-2030)
6.3.3 World Non-Invasive Cancer Detection Market Size Market Share by Application (2019-2030)
7.1 Trublood
7.1.1 Trublood Details
7.1.2 Trublood Major Business
7.1.3 Trublood Non-Invasive Cancer Detection Product and Services
7.1.4 Trublood Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 Trublood Recent Developments/Updates
7.1.6 Trublood Competitive Strengths & Weaknesses
7.2 Datar Cancer Genetics
7.2.1 Datar Cancer Genetics Details
7.2.2 Datar Cancer Genetics Major Business
7.2.3 Datar Cancer Genetics Non-Invasive Cancer Detection Product and Services
7.2.4 Datar Cancer Genetics Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 Datar Cancer Genetics Recent Developments/Updates
7.2.6 Datar Cancer Genetics Competitive Strengths & Weaknesses
7.3 Nucleix
7.3.1 Nucleix Details
7.3.2 Nucleix Major Business
7.3.3 Nucleix Non-Invasive Cancer Detection Product and Services
7.3.4 Nucleix Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Nucleix Recent Developments/Updates
7.3.6 Nucleix Competitive Strengths & Weaknesses
7.4 miR Scientific
7.4.1 miR Scientific Details
7.4.2 miR Scientific Major Business
7.4.3 miR Scientific Non-Invasive Cancer Detection Product and Services
7.4.4 miR Scientific Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 miR Scientific Recent Developments/Updates
7.4.6 miR Scientific Competitive Strengths & Weaknesses
7.5 Owlstone Medical
7.5.1 Owlstone Medical Details
7.5.2 Owlstone Medical Major Business
7.5.3 Owlstone Medical Non-Invasive Cancer Detection Product and Services
7.5.4 Owlstone Medical Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 Owlstone Medical Recent Developments/Updates
7.5.6 Owlstone Medical Competitive Strengths & Weaknesses
7.6 bioAffinity Technologies
7.6.1 bioAffinity Technologies Details
7.6.2 bioAffinity Technologies Major Business
7.6.3 bioAffinity Technologies Non-Invasive Cancer Detection Product and Services
7.6.4 bioAffinity Technologies Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 bioAffinity Technologies Recent Developments/Updates
7.6.6 bioAffinity Technologies Competitive Strengths & Weaknesses
7.7 Nonacus
7.7.1 Nonacus Details
7.7.2 Nonacus Major Business
7.7.3 Nonacus Non-Invasive Cancer Detection Product and Services
7.7.4 Nonacus Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 Nonacus Recent Developments/Updates
7.7.6 Nonacus Competitive Strengths & Weaknesses
7.8 Amadix
7.8.1 Amadix Details
7.8.2 Amadix Major Business
7.8.3 Amadix Non-Invasive Cancer Detection Product and Services
7.8.4 Amadix Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 Amadix Recent Developments/Updates
7.8.6 Amadix Competitive Strengths & Weaknesses
8.1 Non-Invasive Cancer Detection Industry Chain
8.2 Non-Invasive Cancer Detection Upstream Analysis
8.3 Non-Invasive Cancer Detection Midstream Analysis
8.4 Non-Invasive Cancer Detection Downstream Analysis
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Non-Invasive Cancer Detection Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Non-Invasive Cancer Detection Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Non-Invasive Cancer Detection Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Non-Invasive Cancer Detection Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Non-Invasive Cancer Detection Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Non-Invasive Cancer Detection Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Non-Invasive Cancer Detection Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Non-Invasive Cancer Detection Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Non-Invasive Cancer Detection Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Non-Invasive Cancer Detection Players in 2023
Table 12. World Non-Invasive Cancer Detection Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Non-Invasive Cancer Detection Company Evaluation Quadrant
Table 14. Head Office of Key Non-Invasive Cancer Detection Players
Table 15. Non-Invasive Cancer Detection Market: Company Product Type Footprint
Table 16. Non-Invasive Cancer Detection Market: Company Product Application Footprint
Table 17. Non-Invasive Cancer Detection Mergers & Acquisitions Activity
Table 18. United States VS China Non-Invasive Cancer Detection Revenue Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Non-Invasive Cancer Detection Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Non-Invasive Cancer Detection Companies, Headquarters (States, Country)
Table 21. United States Based Companies Non-Invasive Cancer Detection Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Non-Invasive Cancer Detection Revenue Market Share (2019-2024)
Table 23. China Based Non-Invasive Cancer Detection Companies, Headquarters (Province, Country)
Table 24. China Based Companies Non-Invasive Cancer Detection Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Non-Invasive Cancer Detection Revenue Market Share (2019-2024)
Table 26. Rest of World Based Non-Invasive Cancer Detection Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Non-Invasive Cancer Detection Revenue (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Non-Invasive Cancer Detection Revenue Market Share (2019-2024)
Table 29. World Non-Invasive Cancer Detection Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Non-Invasive Cancer Detection Market Size Value by Type (2019-2024) & (USD Million)
Table 31. World Non-Invasive Cancer Detection Market Size by Type (2025-2030) & (USD Million)
Table 32. World Non-Invasive Cancer Detection Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World Non-Invasive Cancer Detection Market Size by Application (2019-2024) & (USD Million)
Table 34. World Non-Invasive Cancer Detection Market Size by Application (2025-2030) & (USD Million)
Table 35. Trublood Basic Information, Manufacturing Base and Competitors
Table 36. Trublood Major Business
Table 37. Trublood Non-Invasive Cancer Detection Product and Services
Table 38. Trublood Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. Trublood Recent Developments/Updates
Table 40. Trublood Competitive Strengths & Weaknesses
Table 41. Datar Cancer Genetics Basic Information, Manufacturing Base and Competitors
Table 42. Datar Cancer Genetics Major Business
Table 43. Datar Cancer Genetics Non-Invasive Cancer Detection Product and Services
Table 44. Datar Cancer Genetics Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. Datar Cancer Genetics Recent Developments/Updates
Table 46. Datar Cancer Genetics Competitive Strengths & Weaknesses
Table 47. Nucleix Basic Information, Manufacturing Base and Competitors
Table 48. Nucleix Major Business
Table 49. Nucleix Non-Invasive Cancer Detection Product and Services
Table 50. Nucleix Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Nucleix Recent Developments/Updates
Table 52. Nucleix Competitive Strengths & Weaknesses
Table 53. miR Scientific Basic Information, Manufacturing Base and Competitors
Table 54. miR Scientific Major Business
Table 55. miR Scientific Non-Invasive Cancer Detection Product and Services
Table 56. miR Scientific Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. miR Scientific Recent Developments/Updates
Table 58. miR Scientific Competitive Strengths & Weaknesses
Table 59. Owlstone Medical Basic Information, Manufacturing Base and Competitors
Table 60. Owlstone Medical Major Business
Table 61. Owlstone Medical Non-Invasive Cancer Detection Product and Services
Table 62. Owlstone Medical Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. Owlstone Medical Recent Developments/Updates
Table 64. Owlstone Medical Competitive Strengths & Weaknesses
Table 65. bioAffinity Technologies Basic Information, Manufacturing Base and Competitors
Table 66. bioAffinity Technologies Major Business
Table 67. bioAffinity Technologies Non-Invasive Cancer Detection Product and Services
Table 68. bioAffinity Technologies Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. bioAffinity Technologies Recent Developments/Updates
Table 70. bioAffinity Technologies Competitive Strengths & Weaknesses
Table 71. Nonacus Basic Information, Manufacturing Base and Competitors
Table 72. Nonacus Major Business
Table 73. Nonacus Non-Invasive Cancer Detection Product and Services
Table 74. Nonacus Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. Nonacus Recent Developments/Updates
Table 76. Nonacus Competitive Strengths & Weaknesses
Table 77. Amadix Basic Information, Manufacturing Base and Competitors
Table 78. Amadix Major Business
Table 79. Amadix Non-Invasive Cancer Detection Product and Services
Table 80. Amadix Non-Invasive Cancer Detection Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. Amadix Recent Developments/Updates
Table 82. Amadix Competitive Strengths & Weaknesses
Table 83. Global Key Players of Non-Invasive Cancer Detection Upstream (Raw Materials)
Table 84. Global Non-Invasive Cancer Detection Typical Customers
List of Figures
Figure 1. Non-Invasive Cancer Detection Picture
Figure 2. World Non-Invasive Cancer Detection Total Revenue: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Non-Invasive Cancer Detection Total Revenue (2019-2030) & (USD Million)
Figure 4. World Non-Invasive Cancer Detection Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Figure 5. World Non-Invasive Cancer Detection Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Non-Invasive Cancer Detection Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Non-Invasive Cancer Detection Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Non-Invasive Cancer Detection Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Non-Invasive Cancer Detection Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Non-Invasive Cancer Detection Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Non-Invasive Cancer Detection Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Non-Invasive Cancer Detection Revenue (2019-2030) & (USD Million)
Figure 13. Non-Invasive Cancer Detection Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Non-Invasive Cancer Detection Consumption Value (2019-2030) & (USD Million)
Figure 16. World Non-Invasive Cancer Detection Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Non-Invasive Cancer Detection Consumption Value (2019-2030) & (USD Million)
Figure 18. China Non-Invasive Cancer Detection Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Non-Invasive Cancer Detection Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Non-Invasive Cancer Detection Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Non-Invasive Cancer Detection Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Non-Invasive Cancer Detection Consumption Value (2019-2030) & (USD Million)
Figure 23. India Non-Invasive Cancer Detection Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Non-Invasive Cancer Detection by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Non-Invasive Cancer Detection Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Non-Invasive Cancer Detection Markets in 2023
Figure 27. United States VS China: Non-Invasive Cancer Detection Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Non-Invasive Cancer Detection Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Non-Invasive Cancer Detection Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Non-Invasive Cancer Detection Market Size Market Share by Type in 2023
Figure 31. Imaging Test
Figure 32. Nuclear Medicine Test
Figure 33. Others
Figure 34. World Non-Invasive Cancer Detection Market Size Market Share by Type (2019-2030)
Figure 35. World Non-Invasive Cancer Detection Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 36. World Non-Invasive Cancer Detection Market Size Market Share by Application in 2023
Figure 37. Prostate Cancer
Figure 38. Bladder Cancer
Figure 39. Pancreatic Cancer
Figure 40. Breast Cancer
Figure 41. Gastric Cancer
Figure 42. Others
Figure 43. World Non-Invasive Cancer Detection Market Size Market Share by Application (2019-2030)
Figure 44. Non-Invasive Cancer Detection Industrial Chain
Figure 45. Methodology
Figure 46. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Trublood Datar Cancer Genetics Nucleix miR Scientific Owlstone Medical bioAffinity Technologies Nonacus Amadix
01 Oct 2024
Service & Software
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
